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Abstract Cardiac dysfunction is associated with diabetes. It
was previously shown that heart mitochondria from diabetic
rats have a reduced calcium accumulation capacity. The objec-
tive of this work was to determine whether the reduction in
calcium accumulation by cardiac mitochondria from diabetic
rats is related to an enhanced susceptibility to induction of the
mitochondrial permeability transition. Streptozotocin-induced
diabetic rats were used as a model to study the alterations
caused by diabetes in the permeability transition, 21 days after
streptozotocin administration. Heart mitochondria were isolated
to evaluate respiratory parameters and susceptibility to the cal-
cium-dependent permeability transition. Our results show that
streptozotocin diabetes facilitates the mitochondrial permeabil-
ity transition in cardiac mitochondria, resulting in decreased
mitochondrial calcium accumulation. We also observed that
heart mitochondria from diabetic rats had depressed oxygen
consumption during the phosphorylative state. The reduced mi-
tochondrial calcium uptake observed in heart mitochondria from
diabetic rats is related to an enhanced susceptibility to the per-
meability transition rather than to damage to the calcium up-
take machinery.
' 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Diabetes mellitus is one of the most common metabolic
diseases in the world. The complications associated with this
disease are often responsible for a decreased quality of life in
many patients. The diabetic population has a greater proba-
bility to su¡er from cardiovascular problems and heart failure
than the general population.
The role of mitochondria in the development of cardiac
dysfunction has not been studied in detail, despite some ex-
periments conducted in isolated liver mitochondria [1]. In
heart mitochondria, streptozotocin (STZ)-induced diabetes
was shown to impair mitochondrial oxidative phosphorylation
and calcium loading capacity, in close relation to observed
diastolic dysfunction [2]. The results were con¢rmed by Tana-
ka et al. [3] using permeabilized myocytes from STZ-injected
animals. One of the negative conditions that can a¡ect mito-
chondrial function is the mitochondrial permeability transi-
tion (MPT), caused by the formation of polyprotein pores
(MPTP), occurring with mitochondrial calcium overload and
oxidative stress, and leading to mitochondrial dysfunction and
even cell death [4].
The aim of this work was to determine di¡erences in the
susceptibility to the MPT in heart mitochondria from STZ-
induced diabetic and control animals, something that was
previously never demonstrated. Our starting hypothesis was
that the reduced mitochondrial calcium uptake observed in
STZ-induced diabetic rat hearts [2,3] was due to enhanced
MPT induction, with all the consequences to cardiac cell as-
sociated with that condition.
2. Materials and methods
2.1. Materials
All reagents and chemicals used were of the highest grade of purity
commercially available. Calcium Green 5-N was obtained from Mo-
lecular Probes (Eugene, OR, USA).
2.2. Animals
Male Wistar rats (2^3 months) were maintained in our local colony
(Laboratory Animal Research Center, University Hospitals, Coimbra)
with food (URF1, Charles River, France) and water at pH 5.5 (except
during fasting periods). In this study, the ‘Principles of Laboratory
Animal Care’ (NIH publication no. 85-23, revised 1996) were fol-
lowed.
2.3. Induction and characterization of STZ-induced diabetes
Diabetes was induced using STZ, as previously described [5]. Rats
(2^3 months) were randomly divided into two groups of ¢ve animals
each. Diabetes was induced in one group of animals after a 16 h
fasting period with a single i.p. STZ injection, 50 mg/kg. STZ was
dissolved in citrate 100 mM, pH 4.5. Control animals were injected
with citrate. In the following 24 h, animals were orally fed with gly-
cosylated serum in order to avoid hypoglycemia resulting from mas-
sive destruction of L-cells and release of intracellular insulin associ-
ated with STZ treatment [5]. Animals were kept for 21 days before the
experiments. Blood glucose concentration was determined from the
tail vein using a commercial glucometer (Glucometer-Elite, Bayer).
Glycated hemoglobin (HbA1c) was determined at the time of sacri¢ce
through ionic exchange chromatographic assay (Abbott IMx Glicohe-
moglobin, Abbott Laboratories, Portugal).
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2.4. Isolation of mitochondria from rat heart
Rat heart mitochondria were prepared as previously described [6].
2.5. Measurement of mitochondrial transmembrane potential
The mitochondrial transmembrane potential (v8) was estimated
with a tetraphenylphosphonium cation (TPPþ) electrode as described
in [6], at 25‡C in 2 ml of the reaction medium (200 mM sucrose, 10
mM Tris^MOPS, 10 WM EGTA, 5 mM KH2PO4 and 2 WM rotenone,
pH 7.4) supplemented with 1 WM TPPþ, 0.25 Wg oligomycin and 0.5
mg of mitochondria. Mitochondria were energized with 4 mM succi-
nate.
2.6. Mitochondrial oxygen consumption
Oxygen consumption of isolated heart mitochondria was monitored
polarographically with a Clark oxygen electrode. Reactions were car-
ried out, at 25‡C, in 2 ml of the reaction medium (without TPPþ and
with 4 mM succinate). Mitochondria were suspended at a concentra-
tion of 0.5 mg/ml in the respiratory medium. ADP (100 nmol) was
added to induce state 3 respiration. The respiratory control ratio
(RCR) was calculated as the ratio between state 3 and state 4 respi-
ration. The ADP/O was calculated as the number of nmol ADP phos-
phorylated per natom oxygen consumed.
2.7. Extramitochondrial calcium movements
Extramitochondrial free Ca2þ was measured with the £uorescence
probe Calcium Green 5-N. Heart mitochondria (0.2 mg) were sus-
pended in 2 ml of bu¡er containing 200 mM sucrose, 10 mM Tris,
10 WM EGTA, 1 mM KH2PO4, 2 WM rotenone, 4 mM succinate, 0.25
Wg oligomycin/mg protein and 100 nM Calcium Green 5-N. Fluores-
cence was recorded continuously at 25‡C using a Perkin-Elmer LS-
50B £uorescence spectrometer with excitation and emission wave-
lengths of 506 and 531 nm, respectively. Due to the lower amount
of protein used, the amount of phosphate in the reaction bu¡er was
reduced to 1 mM in comparison with the 5 mM used for v8 mea-
surements.
2.8. Statistical analysis
The results are presented as meanTS.E.M. of ¢ve animals for each
group. Comparisons between the groups were made using one-way
analysis of variance two-tailed unpaired t-tests. A P value 6 0.05 was
considered statistically signi¢cant.
3. Results
We observed that the control group had a time-dependent
relative weight gain, in contrast to the STZ group, which lost
body weight (137.0 T 17.8 vs. 92.8 T 3.0%, P6 0.05, n=5
each), probably due to loss of body water. There was also a
sharp increase in the levels of blood glucose in the STZ group,
reaching a plateau approximately 3 days after administration,
with an average value of 469 mg/dl (vs. 90.4 T 6.3, P6 0.0001,
n=5 each). The levels of HbA1c showed that the STZ group
possessed increased levels of these glycated hemoglobin deriv-
atives (11.28T 0.27 vs. 5.73T 0.12, P6 0.0001, n=5 each).
As the experiments involving MPTP susceptibility were
done with succinate-energized mitochondria, our bioenergetic
parameters were only tested with that substrate. No di¡eren-
ces were found when measuring state 4 respiration (67.3 T 0.7
for the control group vs. 55.3 T 6.4 for the STZ group, values
in natoms O/min/mg protein, n=5 each). A signi¢cant di¡er-
ence in state 3 respiration (ADP-stimulated respiration) was
found in between the two groups (218.9 T 8.3 for the control
group vs. 160.6T .17.2 for the STZ group, values in natoms
O/min/mg protein, P6 0.05, n=5 each). No signi¢cant dif-
ferences were found in all other parameters, including the
ADP/O ratio (1.62T 0.06 for the control group vs. 1.68T
.0.19 for the STZ group, n=5 each) and the RCR (2.85T
0.25 vs. 3.25T 0.12, n=5 each).
After a calcium pulse, heart mitochondria from the control
group were better able to sustain the initial v8 value than
mitochondria from the diabetic STZ group (Fig. 1, upper
panel). Heart mitochondria from the STZ group were not
able to repolarize and su¡ered a complete depolarization pre-
vented by cyclosporin A (Fig. 1, lower panel). As seen in Fig. 1,
lower panel, prior to calcium addition, no di¡erences in v8
were observable between both groups, even in the presence of
cyclosporin A. A direct visualization of mitochondrial calcium
uptake and release was performed using an extramitochon-
drial £uorescent calcium probe (Fig. 2). After a calcium pulse
(700 nmol/mg protein), mitochondria from both groups accu-
mulated the same amount of calcium. Following that, mito-
chondria from the STZ group were not able to retain the
accumulated calcium, and began releasing it to the bu¡er.
In the presence of cyclosporin A, both types of mitochondria
were able to retain the same amount of calcium. Sixteen hun-
dred seconds after the start of each experiment, extramito-
chondrial calcium levels were much higher in heart mitochon-
dria from STZ-injected animals. Taken together, these results
indicate that heart mitochondria from STZ-induced diabetic
rats have a depressed capacity to accumulate calcium, by way
of an enhanced sensitivity to induction of MPT.
Fig. 1. Upper panel: Representative recording of mitochondrial elec-
tric potential measured by a TPPþ-selective electrode (n=5 each).
Calcium (800 nmol/mg protein) was added in order to induce the
MPTP. v8 was calculated without correction for TPPþ passive
binding to mitochondrial membranes. 0.5 mg mitochondrial protein
was resuspended in 2 ml reaction medium (200 mM sucrose, 10
mM Tris, 10 WM EGTA and 5 mM KH2PO4, supplemented with
2 WM rotenone, 0.25 Wg oligomycin and 1 WM TPPþ). Mitochondrial
energization was achieved with 4 mM succinate. Cyclosporin A
(CyA, 1 WM) was added to the mitochondrial suspension before en-
ergization. Numbers on the ordinates represent mitochondrial v8
(3mV). Lower panel: statistical treatment of data. Displayed are
the v8 values prior to calcium addition (black bars) and the highest
v8 value reached by mitochondrial after calcium addition (white
bars). *P6 0.001 vs. pre-calcium STZ, **P6 0.001 vs. STZ+CyA,
#P6 0.001 vs. post-calcium STZ, n=5 each.
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4. Discussion
A relationship between dysfunctional cardiac work and de-
fective mitochondrial function associated with diabetes has
been previously reported [2]. This elegant study showed a
reduced calcium uptake in heart mitochondria from STZ-in-
jected rats, although the primary reason was not found. STZ
is an established animal model to generate diabetic cardiomy-
opathy [5]. In another model of STZ-induced diabetic mito-
chondriopathy, Tanaka et al. [3] also showed a reduced mi-
tochondrial calcium accumulation in permeabilized myocytes,
although the reason was again not described.
The hypothesis for this work was that the MPT, a delete-
rious condition triggered by excessive calcium and oxidative
stress [4], could account for the decreased calcium uptake by
heart mitochondria from diabetic rats [2,3].
Our results revealed that both groups of mitochondria ac-
cumulated the same amount of calcium in the presence of
cyclosporin A. This compound, a known MPTP inhibitor
[7], inhibited the v8 depolarization after calcium uptake
and allowed mitochondria from STZ rats to accumulate cal-
cium, identically to control mitochondria. The data suggest
that the depressed calcium uptake was not due to dysfunc-
tional calcium uptake machinery, nor to enhanced calcium
release by MPT-independent processes, which is in agreement
with previous reports [2]. Heart mitochondria from the STZ
group also showed a lower state 3 respiration. The unchanged
ADP/O value suggests that the mitochondrial phosphorylative
machinery may not have been a¡ected in our model. Instead,
the result suggests alterations at the level of the respiratory
chain. Kristal et al. [1] observed a defect in hepatic mitochon-
drial complex III of STZ-injected rats. Kucharska et al. [8]
demonstrated a de¢cit of coenzyme Q in heart mitochondria
of rats with STZ-induced diabetes. The described alterations,
although not apparent during mitochondrial state 4, may hin-
der the maximal rate of state 3 respiration in our STZ exper-
imental model.
The enhanced MPT induction and reduced state 3 respira-
tion hint that heart mitochondria from STZ-injected animals
may su¡er from two distinct functional defects, depending on
the presence of calcium. The lower state 3 occurred under
conditions in which extramitochondrial calcium levels were
very low or absent (as the experiments were made in a bu¡er
containing EGTA and in the absence of externally added
calcium). When calcium was added, a new defective mito-
chondrial function was revealed in diabetic animals: a lower
calcium loading capacity. Under the conditions we used for
measuring mitochondrial oxygen consumption, MPT induc-
tion is supposedly not a factor due to the absence of calcium.
Nevertheless, it cannot bee excluded that in vivo, other alter-
ations in mitochondrial oxygen consumption parameters may
occur (like a decreased ADP/O ratio or increased state 4 res-
piration), especially when heart mitochondria are called to
deal with above-physiological calcium concentrations with
consequent increased MPT induction. Nevertheless, the re-
duced respiration during the phosphorylation state does not
require the presence of calcium and may be present under
resting (physiological) conditions.
The results of this study also appear to be contradictory
with previous reports from our group when using another
animal model for diabetes, the Goto-Kakizaki (GK) rat [9].
We showed that heart mitochondria from GK rats possess a
decreased susceptibility to the MPT. Nevertheless, there are
di¡erences between both types of animals and the transposi-
tion to a clinical context may not be immediate. The average
blood glucose levels are much smaller in the GK rat than in
the STZ rat, so GK rats are considered to display a milder
and hereditary form of diabetes ([9] and references therein). In
fact, the GK rat much better resembles the typical diabetic
patient with absent or mild chronic cardiovascular problems,
while the STZ animal model (widely studied in the literature)
should be regarded as a model for short-term hyperglycemic
crisis or for late forms of severe diabetes (and not for cardiac
dysfunction of the typical diabetic patient). In this context, the
relation between di¡erences in the susceptibility to the MPT
and the severity of the hyperglycemic episode may help ex-
plain contradictory results in the literature, concerning the
resistance of the diabetic heart to acute ischemia^reperfusion
damage [10,11]. In fact, the authors stated that the resistance
Fig. 2. Upper panel: Representative recording of extramitochondrial
calcium movements measured using the £uorescent calcium-sensitive
probe Calcium Green 5-N (n=5 each). 0.2 mg of protein was resus-
pended in 2 ml of medium containing 200 mM sucrose, 10 mM
Tris, 10 WM EGTA, 1 mM KH2PO4, 2 WM rotenone and 0.05 Wg
oligomycin. Mitochondrial energization was achieved with 4 mM
succinate. A pulse of 700 nmol calcium per mg protein was added
to the mitochondrial suspension. Free extramitochondrial Ca2þ was
monitored with 100 nM Calcium Green 5-N. EGTA was added at
the end of each experiment to calculate the basal line. Extramito-
chondrial calcium was determined as described in Section 2. Cyclo-
sporin A (CyA, 0.2 WM) was added before calcium addition. Lower
panel: Extramitochondrial calcium concentration measured 1600 s
after the start of each experiment. *P6 0.001 vs. control and vs.
STZ+CyA, n=5 each.
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to cardiac ischemia and reperfusion appears to be directly
related to the severity of the diabetic condition.
The link between di¡erent hyperglycemia levels and di¡er-
ential MPTP induction has still to be explored. Diabetes is
often associated with increased oxidative stress [12], a condi-
tion known to induce the MPT via the oxidation of critical
thiol residues (for a review, see [4]). In fact, oxidative stress
was already observed in the hearts of STZ-injected animals
[13,14]. We can speculate that the defect found in mitochon-
drial complex III by Kristal et al. [1] may, in fact (as the
authors proposed) lead to increased reactive oxygen species
generation by the mitochondrial respiratory chain, a fact that
could be exacerbated by the presence of calcium. The absence
of di¡erences in mitochondrial v8 before calcium addition
(Fig. 1, pre-calcium) led us to think that a possible voltage
di¡erence between the experimental groups was not a cause
for di¡erential MPT gating.
Sustained enhancement of MPTP openings in heart mito-
chondria from STZ-injected animals may induce a decrease in
mitochondrial ATP production, large amplitude swelling as
well as cell death and reduced resistance to acute ischemia
followed by reperfusion [4]. It is also known that constant
oxidative stress may lead to the activation of one potential
mechanism for mitochondrial defense, the so-called mitochon-
drial mild uncoupling, in which small decreases of membrane
potential, not enough to hinder ATP production, may de-
crease the amount of free radicals produced by the respiratory
chain [15]. We may speculate that a low conductance form of
the MPT may exist in vivo in STZ-injected animals, leading to
mild mitochondrial uncoupling as an ultimate defense. Con-
stant oxidative stress and MPT activation would later lead to
irreversible mitochondrial and cellular damage, with the con-
sequences described above. In our experimental conditions,
and in the absence of calcium, no signi¢cant decrease in mi-
tochondrial v8 in succinate-energized mitochondria was ob-
served, suggesting that the mild uncoupling mechanism may
not be fully functional in the absence of calcium.
Our results are also in contradiction with the ones obtained
by Kristal et al. [16]. The authors observed that the MPT was
decreased in the livers of STZ-induced diabetic rats. There is
no unique explanation for this. Heart and liver possess di¡er-
ent signaling pathways and antioxidant defense reserves and
so may respond di¡erently to hyperglycemia and oxidative
stress. This may explain why the heart is primarily a¡ected
during the course of diabetes.
The results may also contribute to explain why severe hy-
perglycemia was observed to lead to mitochondria-mediated
cell death [17]. In opposition, mild chronic glycemia (as in GK
rats) appears to up-regulate anti-apoptotic proteins [18],
which may represent an adaptation response to a chronic
(but again, mild) condition. A possible relation between the
increased expression of anti-apoptotic proteins and MPTP
induction has not been explored yet in the context of milder
forms of diabetes.
Our observations o¡er important insights, not only to ex-
plain the reduced resistance to cardiac ischemia and reperfu-
sion observed in patients with more severe forms of diabetes,
but also for the design of new therapeutic approaches to re-
duce mitochondrial dysfunction and cell death typically asso-
ciated with diabetes.
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